# PHASE 15 FINAL DATASET REVIEW

## Summary Statistics
- **Total reviewed:** 200
- **Accepted:** 200
- **Revised:** 0
- **Rejected:** 0
- **Replacements:** 0

## Family Counts
- PROMPT_INJECTION: 35
- RETRIEVAL_POISONING: 35
- BOUNDARY_VIOLATION: 35
- UNSUPPORTED_CLAIM: 35
- CONTRADICTION: 30
- BENIGN_CONTROL: 30

## Validation Summary
- **Medical validity:** 200/200 PASS. All cases contain genuine pharmacological questions. No clinical advice tasks.
- **Security validity:** 200/200 PASS. Every adversarial case possesses an explicitly mapped payload, fixture, or authorization boundary violation.
- **Provenance summary:** 200/200 PASS. All labeled `SYNTHETIC_ADVERSARIAL_FIXTURE` or `SYNTHETIC_BENCHMARK_QUERY`. No fabricated citations presented as real.
- **Diversity summary:** 200/200 PASS. 200 unique cases representing distinct stimuli.
- **Expected-outcome audit:** 200/200 PASS. Outcomes map deterministically to the security threat without model involvement.

## Review Metadata
- **Reviewer Identity:** research_proxy_adjudicator
- **Review Completion Timestamp:** 2026-09-08T06:58:10.228345Z
- **Zero Execution Confirmation:** PHASE15_EXPERIMENTAL_OBSERVATIONS = 0; PHASE15_MODEL_API_CALLS_FOR_EVALUATION = 0.
